Cytokinetics (CYTK) EBT Margin (2010 - 2026)
Cytokinetics (CYTK) posted EBT Margin of -351.34% for Q3 2026, up 8848.45 percentage points from -9199.79% a year earlier and up 274.61 percentage points from the prior quarter.
Cytokinetics (CYTK) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBT Margin at Cytokinetics was -637.75%, up 70.83 percentage points year-over-year; for FY2025, it came in at -747.21%.
- Annual EBT Margin shows a five-year change of -550.35 percentage points (FY2020 to FY2025).
- In prior years, Cytokinetics' EBT Margin was -6965.62% in FY2023 (-6602.34 pp), -363.28% in FY2022 (-75.39 pp) and -287.89% in FY2021 (-91.02 pp).
- The Q3 2026 figure stands as the highest quarterly EBT Margin since Q2 2025.
- On a year-over-year basis, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +13842.11 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q2 2025, with a gain of 57207.56 percentage points; the weakest was Q2 2024, with a drop of 42501.43 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -625.95% (Q2 2026), -948.69% (Q1 2026) and -1084.99% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn | -351.34% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -351.34% |
| Jun 30, 2026 | -625.95% |
| Mar 31, 2026 | -948.69% |
| Dec 31, 2025 | -1,084.99% |
| Sep 30, 2025 | -9,199.79% |
| Jun 30, 2025 | -183.60% |
| Mar 31, 2025 | -9,856.30% |
| Dec 31, 2024 | -986.52% |
| Sep 30, 2024 | -32,338.88% |
| Jun 30, 2024 | -57,391.16% |
| Mar 31, 2024 | -15,968.62% |
| Dec 31, 2023 | -8,049.16% |
| Sep 30, 2023 | -34,233.07% |
| Jun 30, 2023 | -14,889.73% |
| Mar 31, 2023 | -2,849.21% |
| Dec 31, 2022 | -6,851.66% |
| Sep 30, 2022 | -4,582.31% |
| Jun 30, 2022 | -15.38% |
| Mar 31, 2022 | -7,021.17% |
| Dec 31, 2021 | -46.62% |
Cytokinetics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();